Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Nankoku
Clinical trial register · Japan

Clinical Trials in Nankoku, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Japan and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2516 matching records held by the registry are in this view. Synced 12 Nov 2026, 03:19 UTC
2516
Studies in scope
all four open statuses
1285
Recruiting now
open to new participants
352
Lead sponsors
across recruiting studies
Top sites
Fukuoka 557 Nagoya 513 Sapporo 400 Tokyo 375 Osaka 354

Trials with a site in Nankoku

15 of 2516 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Japan
Start
Recruiting
BeOne Medicines
Phase 3
500
Nagoya, Nakamuraku, Matsuyama, Fukushima, Hiroshima, Sapporo, Nankoku, Kumamoto
2025-09-04
Active, closed
Bayer
Phase 3
36
Kurume, Himeji, Kobe, Tsukuba, Morioka, Sagamihara, Yokohama, Nankoku
2025-06-30
Recruiting
Immunovant Sciences GmbH
Phase 2
210
Nagoya, Kamogawa, Kitakyushu, Kurume, Minokamo, Maebashi, Yokohama, Nankoku
2025-06-19
Active, closed
Ono Pharmaceutical Co., Ltd.
Phase 1
35
Nagoya, Kashiwa, Kurume, Nishinomiya, Sagamihara, Yokohama, Nankoku, Kyoto
2025-04-21
Active, closed
Merck Sharp & Dohme LLC
Phase 3
67
Toyoake, Tōon, Kitakyushu, Takarazuka, Yokohama, Nankoku, Natori-shi, Sakai
2024-11-21
Active, closed
Merck Sharp & Dohme LLC
Phase 3
473
Nagoya, Kashiwa, Nankoku, Kitaadachi-gun, Chūō, Koto, Fukuoka, Osaka
2024-05-03
Active, closed
Incyte Corporation
Phase 3
467
Hamamatsu, Kawasaki, Kobe, Kyoto, Minamikoshigaya, Nagasaki, Nagoya, Nankoku
2023-11-29
Recruiting
Merck Sharp & Dohme LLC
Phase 3
735
Sapporo, Nankoku, Sakai, Izumo, Koto, Hiroshima, Nagasaki, Osaka
2023-08-08
Active, closed
Regeneron Pharmaceuticals
Phase 3
288
Kobe, Nankoku, Ginowan-Shi, Shimajiri, Kawagoe, Bunkyo, Shinjuku, tabashi City
2021-12-14
Active, closed
Loxo Oncology, Inc.
Phase 3
282
Nagoya, Chiba, Yoshida-Gun, Sapporo, Nankoku, Sendai, Koshigaya, Chūō
2021-09-23
Active, closed
Loxo Oncology, Inc.
Phase 3
600
Bunkyō City, Chiba-Ken, Chūō, Chūōku, Fukui, Kōtō City, Kyoto, Nankoku
2021-09-20
Recruiting
Merck Sharp & Dohme LLC
Phase 2
355
Sapporo, Yokohama, Nankoku, Chuo-ku, Kyoto, Tokyo
2021-08-12
Active, closed
Loxo Oncology, Inc.
Phase 3
238
Nagoya, Ogaki-shi, Sapporo, Kobe, Isehara, Nankoku, Sendai, Osaka Sayama-shi
2021-03-09
Active, closed
Alnylam Pharmaceuticals
Phase 3
655
Bunkyō City, Fukuoka, Kashihara, Kita-gun, Kumamoto, Kurume, Matsumoto, Nankoku
2019-11-26
Recruiting
Genzyme, a Sanofi Company
Observational
9,000
Kobe, Nankoku, Chiba, Niigata, Osaka, Tokyo
2001-07-31
Rows per page Showing 1–15 of 15
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Japanese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 November 2026. https://priyalifescience.com/clinical-trials-japan/city/nankoku

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Japan and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,516 studies in total at the last sync on 12 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 15 of those studies with a site in Nankoku.

How many clinical trials are recruiting in Nankoku?

5 of the 15 studies on this page are recruiting new participants as of the 12 Nov 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 10 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Nankoku), 15 studies
PhaseStudiesRecruitingShare
Phase 311273.3%
Phase 22213.3%
Observational116.7%
Phase 1106.7%

Most active sponsors

Lead sponsors with the most studies (Nankoku)
Lead sponsorStudiesRecruiting
Merck Sharp & Dohme LLC42
Loxo Oncology, Inc.30
Alnylam Pharmaceuticals10
Bayer10
BeOne Medicines11
Genzyme, a Sanofi Company11
Immunovant Sciences GmbH11
Incyte Corporation10
Ono Pharmaceutical Co., Ltd.10
Regeneron Pharmaceuticals10
→

Other trial registries in Japan

This register lists Japan studies from ClinicalTrials.gov. Many studies in Japan are registered only in a national registry. We do not copy those records; search them directly:

  • jRCT (Japan Registry of Clinical Trials) — run by the Ministry of Health, Labour and Welfare; trials under Japan's Clinical Trials Act and other clinical research
  • UMIN-CTR — run by the University of Tokyo Hospital's UMIN Center; many academic and investigator-led studies
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.